• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10623
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Heart Failure (2206)
Event Date 12/01/2020
Event Type  Death  
Event Description
Synergy (b)(6) registry.It was reported that the patient died.In (b)(6) 2019, the subject was referred for cardiac catherization.The index procedure was performed and the subject was enrolled on the same day.The target lesion was located in the distal left circumflex artery (lcx) with 85% stenosis and was 35mm long with a reference vessel diameter of 2.75mm.The lesion treated with direct deployment of a 2.75mm x 38mm synergy stent system.Following post-dilatation the residual stenosis was 5%.Two weeks and four days later, the subject was discharged on aspirin and ticagrelor.In (b)(6) 2020, the subject experienced cardiac insufficiency and on an unknown date the subject expired with an unknown cause of death.No action was taken to treat the event and it is unknown if an autopsy was performed.No other additional information is available at this time of report.
 
Manufacturer Narrative
E1 initial reporter address 1: (b)(6).Correction: b3 event date: (b)(6) 2020, initially reported.And correct event date should have been (b)(6) 2020.No event date was provided.Therefore, the first date of the month of the aware date was used.
 
Event Description
Synergy china registry: it was reported, that the patient died.In (b)(6) 2019, the subject was referred for cardiac catherization.The index procedure was performed, and the subject was enrolled on the same day.The target lesion was located in the distal left circumflex artery (lcx) with 85% stenosis, and was 35mm long with a reference vessel diameter of 2.75mm.The lesion treated with direct deployment of a 2.75mm x 38mm synergy stent system.Following post-dilatation, the residual stenosis was 5%.Two weeks and four days later, the subject was discharged on aspirin and ticagrelor.In (b)(6) 2020, the subject experienced cardiac insufficiency.And on an unknown date, the subject expired with an unknown cause of death.No action was taken to treat the event.And it is unknown, if an autopsy was performed.No other additional information is available at this time of report.
 
Manufacturer Narrative
E1: initial reporter address 1: (b)(6).
 
Event Description
Synergy china registry.It was reported that the patient died.On (b)(6) 2019, the subject was referred for cardiac catherization.The index procedure was performed and the subject was enrolled on the same day.The target lesion was located in the distal left circumflex artery (lcx) with 85% stenosis and was 35mm long with a reference vessel diameter of 2.75mm.The lesion treated with direct deployment of a 2.75mm x 38mm synergy stent system.Following post-dilatation the residual stenosis was 5%.Two weeks and four days later, the subject was discharged on aspirin and ticagrelor.On (b)(6) 2020, the subject experienced cardiac insufficiency and on an unknown date the subject expired with an unknown cause of death.No action was taken to treat the event and it is unknown if an autopsy was performed.No other additional information is available at this time of report.It was further reported that, per edc, the stent was deployed without any device deficiency.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11059447
MDR Text Key223353598
Report Number2134265-2020-18369
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 01/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/02/2020
Device Model Number10623
Device Catalogue Number10623
Device Lot Number0023953162
Was Device Available for Evaluation? No
Date Manufacturer Received01/13/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age68 YR
-
-